OraSure Technologies, Inc. - Common Stock (OSUR)
Competitors to OraSure Technologies, Inc. - Common Stock (OSUR)
Abbott Laboratories ABT -1.72%
Abbott Laboratories competes with OraSure Technologies primarily in the diagnostics sector, offering a wide range of medical tests and devices, including rapid tests for infectious diseases. Abbott has a more extensive product portfolio and global reach, which provides it with a competitive advantage in terms of brand recognition and sales distribution. While OraSure specializes in oral fluid diagnostics and drug testing, Abbott's resources and investments in R&D allow it to innovate rapidly, making it a formidable competitor in the diagnostics market.
Bio-Rad Laboratories, Inc. BIO -3.31%
Bio-Rad Laboratories competes with OraSure in the lab diagnostics and clinical diagnostics segments, featuring a range of products for life science research and clinical diagnostics. While Bio-Rad has a strong foothold in various diagnostics applications, including immunology and quality control, OraSure is specifically focused on oral fluid testing and rapid diagnostic solutions. Bio-Rad’s scale and diversification provide it with an advantage, allowing it to leverage more resources for R&D and market penetration.
Cepheid (part of Danaher Corporation) DHR -1.33%
Cepheid specializes in molecular diagnostic testing solutions and competes with OraSure Technologies by offering rapid, accurate testing for infectious diseases. Cepheid's competitive advantage rests in its advanced molecular technologies that allow for quick turnaround times and extensive test menus. This positions them favorably in a market increasingly trending towards molecular diagnostics, contrasting with OraSure's focus on oral fluid testing, which is narrower in scope.
QuidelOrtho Corporation QDEL -0.89%
QuidelOrtho Corporation competes with OraSure in the point-of-care diagnostics market, focusing on infectious diseases and reproductive health, including rapid antigen tests. Both companies are vying for market share in the diagnostics field, but QuidelOrtho holds a competitive advantage through its established market presence and a robust lineup of rapid test products that are widely adopted in hospitals and clinics. Their continuing innovations and collaborations in diagnostic solutions put them in a strong competitive position against OraSure.
Thermo Fisher Scientific Inc. TMO +0.12%
Thermo Fisher Scientific competes indirectly with OraSure Technologies by providing a vast array of laboratory equipment, reagents, and diagnostic tools. While OraSure focuses on specific diagnostic and sample collection solutions, Thermo Fisher's competitive advantage lies in its comprehensive service offerings and infrastructure supporting research and clinical applications. This allows Thermo Fisher to cover broader facets of the diagnostics spectrum compared to OraSure’s more niche market focus.